Skip to main content
logo
Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.140
-0.030 (-1.38%)
At close: Aug 26, 2026, 4:00 PM EDT
2.135
-0.005 (-0.23%)
After-hours: Aug 26, 2026, 7:30 PM EDT

Century Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-109.79-9.58-126.57-136.67-130.93-95.82
Depreciation & Amortization
12.313.113.313.048.443.75
Other Amortization
---0.090.30.31
Asset Writedown & Restructuring Costs
6.766.764.3316.37--
Loss (Gain) From Sale of Investments
-1.22-2.36-4.81-3.98--
Stock-Based Compensation
5.596.8412.6914.6210.674.73
Other Operating Activities
3-4.090.2-1.21.630.83
Change in Accounts Payable
1.611.56-1.47-2.36-4.79-1.85
Change in Unearned Revenue
--109.16-6.59-2.24117.99-
Change in Other Net Operating Assets
-5.01-6.95-1.2213.9810.75-0.95
Operating Cash Flow
-86.76-103.88-110.14-88.3514.05-89
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.33-0.85-0.15-13.74-30.6-44.97
Cash Acquisitions
---9.61---
Investment in Securities
-46.54108.3557.2474.8717.48-253.37
Investing Cash Flow
-47.82107.547.4861.13-13.13-298.34

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
----10.24--
Net Debt Issued (Repaid)
----10.24--
Issuance of Common Stock
126.990.1774.560.5227.16277.07
Other Financing Activities
------18.92
Financing Cash Flow
126.990.1774.56-9.7327.16417.77

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-7.593.811.91-36.9428.0830.43

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-88.09-104.72-110.29-102.08-16.55-133.97
Free Cash Flow Growth
------
Free Cash Flow Margin
--95.93%-1673.84%-4567.52%-318.37%-
Free Cash Flow Per Share
-0.61-1.21-1.40-1.72-0.29-4.14
Levered Free Cash Flow
-50.41-97.2149.44-71.09-79.59-96.45
Unlevered Free Cash Flow
-50.41-97.2149.44-70.85-79-95.96

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
---0.591.10.97
Cash Income Tax Paid
--0.52.52-0.01
Change in Working Capital
-3.4-114.55-9.289.38123.95-2.8
SEC Filings: 10-K · 10-Q